Drug reimbursement reforms could increase price volatility, warns negotiator

Community Pharmacy England said a move to quarterly updating of Category A reimbursement prices could have an "unknown impact" on medicines supply chains.
drugs on pharmacy shelves
Under the reforms, the reimbursement prices of medicines in Category A will be updated quarterly rather than monthly

LEWIS HOUGHTON/SCIENCE PHOTO LIBRARY

Changes to the way drug reimbursement prices are set “could increase price volatility and the need for price concessions”, Community Pharmacy England (CPE) has warned.

Register for free to keep on reading

Access two premium articles as a registered user.

Register

Already an RPS member or registered? Log in

Register for free to keep on reading

Access two premium articles as a registered user.

Register

Already an RPS member or registered? Log in

Register for free to keep on reading

Access two premium articles as a registered user.

Register

Already an RPS member or registered? Log in

Register for free to keep on reading

Access two premium articles as a registered user.

Register

Already an RPS member or registered? Log in

Last updated